The search for plasmodium falciparum histidine-rich protein 2/3 deletions in Zambia and implications for plasmodium falciparum histidine-rich protein 2-based rapid diagnostic tests

American Journal of Tropical Medicine and Hygiene

Volumn 100, Issue 4, 2019, Pages 842-845

  Kobayashi, Tamaki ^a   Sikalima, Jay ^b   Parr, Jonathan B ^c   Chaponda, Mike ^b   Stevenson, Jennifer C ^a,d   Thuma, Philip E ^d   Mulenga, Modest ^b   Meshnick, Steven R ^e   Moss, William J ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b TROPICAL DISEASES RESEARCH CENTRE   (Zambia)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d Macha Research Trust   (Zambia)

^e University of North Carolina at Chapel Hill   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTIDINE RICH PROTEIN 2; HISTIDINE RICH PROTEIN 3; PROTOZOAL DNA; PROTOZOAL PROTEIN; UNCLASSIFIED DRUG; HRP-2 ANTIGEN, PLASMODIUM FALCIPARUM; HRP3 PROTEIN, PLASMODIUM FALCIPARUM; PARASITE ANTIGEN;

ADULT; ARTICLE; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRIED BLOOD SPOT TESTING; GENE; GENE DELETION; HUMAN; MALARIA FALCIPARUM; MOLECULAR DIAGNOSIS; NONHUMAN; PARASITE IDENTIFICATION; PFHRP2 GENE; PFHRP3 GENE; PLASMODIUM FALCIPARUM; ZAMBIA; GENETICS;

ANTIGENS, PROTOZOAN; CROSS-SECTIONAL STUDIES; DNA, PROTOZOAN; DRIED BLOOD SPOT TESTING; GENE DELETION; HUMANS; MALARIA, FALCIPARUM; MOLECULAR DIAGNOSTIC TECHNIQUES; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; ZAMBIA;

EID: 85064239173     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.18-0859     Document Type: Article

References (18)

1. Cheng Q, Gatton ML, Barnwell J, Chiodini P, McCarthy J, Bell D, CunninghamJ, 2014. Plasmodiumfalciparum parasites lacking histidine-rich protein 2 and 3: A review and recommendations for accurate reporting. Malar J 13: 283.
2. Gendrot M, Fawaz R, Dormoi J, Madamet M, Pradines B, 2018. Genetic diversity and deletion of Plasmodium falciparum histidine-rich protein 2 and 3: A threat todiagnosis of P. falciparum malaria. Clin Microbiol Infect. Epub ahead of print. Available at: Https://www.ncbi.nlm.nih.gov/pubmed/30267926.
3. BerhaneAet al., 2018. Major threat to malaria control programs by Plasmodium falciparum lacking histidine-rich protein 2, Eritrea. Emerg Infect Dis 24: 462-470.
4. Wellems TE, Howard RJ, 1986. Homologous genes encode two distinct histidine-rich proteins in a cloned isolate of Plasmodium falciparum. Proc Natl Acad Sci U S A 83: 6065-6069.
5. Yukich JO et al., 2012. Reductions in artemisinin-based combination therapy consumption after the nationwide scale up of routine malaria rapid diagnostic testing in Zambia. Am J Trop Med Hyg 87: 437-446.
6. PMI, 2018. FY 2018 Zambia Malaria Operational Plan-President's Malaria Initiative. Available at: Https://www.pmi. gov/docs/default-source/default-document-library/malariaoperational-plans/fy-2018/fy-2018-zambia-malaria-operationalplan. pdf?sfvrsn=7. Accessed October 23, 2018.
7. Stresman GH, Kamanga A, Moono P, Hamapumbu H, Mharakurwa S, Kobayashi T, Moss WJ, Shiff C, 2010.A method of active case detection to target reservoirs of asymptomatic malaria and gametocyte carriers in a rural area in Southern Province, Zambia. Malar J 9: 265.
8. Laban NM, Kobayashi T, Hamapumbu H, Sullivan D, Mharakurwa S, Thuma PE, Shiff CJ, Moss WJ; Southern Africa International Centers of Excellence for Malaria R, 2015. Comparison of a PfHRP2-based rapid diagnostic test and PCR for malaria in a low prevalence setting in rural southern Zambia: Implications for elimination. Malar J 14: 25.
9. Kanyangarara M et al.; Southern Africa International Centers of Excellence for Malaria R, 2018. Malaria knowledge and bed net use in three transmission settings in southern Africa. Malar J 17: 41.
10. Pinchoff J, Chaponda M, Shields TM, Sichivula J, Muleba M, Mulenga M, Kobayashi T, Curriero FC, Moss WJ; Southern Africa International Centers of Excellence for Malaria R, 2016. Individual and household level risk factors associated with malaria in Nchelenge district, a region with perennial transmission: A serial cross-sectional study from 2012 to 2015. PLoS One 11: E0156717.
11. WHO, 2017.MalariaRapidDiagnosticTestPerformance-Resultsof WHO Product Testing of Malaria RDTs: Round 7 (2015-2016). Available at: Https://www.who.int/malaria/publications/atoz/ 978924151268/en/. Accessed October 23, 2018.
12. Steenkeste N et al., 2009. Towards high-throughput molecular detection of Plasmodium: new approaches and molecular markers. Malar J 8: 86.
13. Snounou G, Viriyakosol S, Jarra W, Thaithong S, Brown KN, 1993. Identification of the four human malaria parasite species in field samples by the polymerase chain reaction and detection of a high prevalence of mixed infections. Mol Biochem Parasitol 58: 283-292.
14. Parr JB et al., 2017. Pfhrp2-Deleted Plasmodium falciparum parasites in the Democratic Republic of the Congo: A national cross-sectional survey. J Infect Dis 216: 36-44.
15. Akter J, Thriemer K, Khan WA, Sullivan DJ Jr., Noedl H, Haque R, 2012. Genotyping of Plasmodium falciparum using antigenic polymorphic markers and to study anti-malarial drug resistance markers in malaria endemic areas of Bangladesh. Malar J 11: 386.
16. Parr JB, Anderson O, Juliano JJ, Meshnick SR, 2018. Streamlined, PCR-based testing for pfhrp2-and pfhrp3-negative Plasmodium falciparum. Malar J 17: 137.
17. Baker J, McCarthy J, GattonM, Kyle DE, Belizario V, Luchavez J, Bell D, Cheng Q, 2005. Genetic diversity of Plasmodium falciparum histidine-rich protein 2 (PfHRP2) and its effect on the performance of PfHRP2-based rapid diagnostic tests. J Infect Dis 192: 870-877.
18. Pringle JC, Carpi G, Almagro-Garcia J, Zhu SJ, Kobayashi T, Mulenga M, Bobanga T, Chaponda M, Moss WJ, Norris DE, 2018. RTS, S/AS01 malaria vaccine mismatch observed among Plasmodium falciparum isolates from Southern and Central Africa and globally. Sci Rep 8: 6622.